Oncolys BioPharma News

Oncolys BioPharma: Notice regarding fast track designation of OBP-601 (censavudine, TPN-101) for progressive supranuclear palsy (PSP)

May 22 07:00

Oncolys BioPharma: Confirmation letter

May 10 14:08

Oncolys BioPharma: Quarterly Report - 21st Quarter (2024/01/01 to 2024/03/31)

May 10 14:07

Oncolys BioPharma: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses

May 10 14:00

Oncolys BioPharma: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

May 10 14:00

Oncolys BioPharma: Unconsolidated financial results for the three months ended 2024/3/31 [Japanese GAAP]

May 10 14:00

Oncolis Biopharma: Notice regarding responses to inquiries

Apr 9 14:00

Oncolys BioPharma: Notice of publication of the log me finance transcript of the business briefing

Apr 3 13:15

Oncolys BioPharma: Extraordinary Report

Apr 3 08:44

Oncolys BioPharma: Corporate Governance Report 2024/04/02

Apr 2 12:55

Oncolis Biopharma: Notice Concerning Mass Exercise of the 19th Stock Acquisition Rights (with Exercise Price Amendment Clauses), Monthly Exercise Status, and Completion of Exercise of Rights

Mar 29 15:05

Oncolis Biopharma: Business Briefing Materials

Mar 29 14:00

Oncolys BioPharma: Financial Report - 20th Term (2023/01/01 - 2023/12/31)

Mar 29 08:21

Oncolys BioPharma: Confirmation letter

Mar 29 08:20

Oncolys BioPharma: Internal Control Report - 20th Term (2023/01/01 - 2023/12/31)

Mar 29 08:19

Oncolis Biopharma: Notice regarding resolution results etc. of the Annual General Meeting of Shareholders

Mar 28 14:00

Oncolys BioPharma: Matters relating to business plans and growth potential

Mar 26 14:00

Oncolys BioPharma: Notice regarding responses to inquiries

Mar 19 10:00

Oncolys BioPharma: Notice Concerning Issuance of New Shares as Stock Compensation with Transfer Restricted Shares

Mar 15 15:00

Oncolis Biopharma: Announcement of the release of the “Oncolis Introduction Video”

Mar 8 14:00